Scientific article
Case report

Antibiotic use in children - off-label use

Published inCurrent drug targets, vol. 13, no. 7, p. 885-892
Publication date2012

Systemic antibiotics are the group of drugs most commonly used in children. Off-label antibiotic use in children is still common in the community and in hospitals, mostly because of young age, dosage, or frequency of drug application. There is an important incentive gap that hinders paediatric drug development resulting from a series of factors, such as small market size, a predominance of off-patent use, no incentives for generic drug manufacturers, and a greater complexity of drug development. The latter is due to varying capacities of drug absorption and metabolism during growth and maturation and the need for oral formulations in neonates and infants. High ethical barriers, combined with concerns of parents about drug safety, further complicate the conduct of clinical studies in children. While many off-patent antibiotics today are labelled for use in children, newer substances such as fluoroquinolones, azithromycin, linezolid, or daptomycin are not. This is of concern in the light of emerging multidrug-resistant pathogens.

  • Ambulatory Care
  • Anti-Bacterial Agents/therapeutic use
  • Child
  • Child, Preschool
  • Drug Utilization Review
  • Humans
  • Infant
  • Infant, Newborn
  • Off-Label Use
Citation (ISO format)
ZINGG, Walter, POSFAY BARBE, Klara. Antibiotic use in children - off-label use. In: Current drug targets, 2012, vol. 13, n° 7, p. 885–892.
Main files (1)
Article (Published version)
ISSN of the journal1389-4501

Technical informations

Creation10/24/2013 11:00:00 AM
First validation10/24/2013 11:00:00 AM
Update time03/14/2023 8:34:59 PM
Status update03/14/2023 8:34:59 PM
Last indexation01/16/2024 8:02:49 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack